PRELUDE THERAPEUTICS INC (PRLD)

US74065P1012 - Common Stock

1.19  -0.05 (-4.03%)

After market: 1.1885 0 (-0.13%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to PRLD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.51. This target is 362.86% above the current price.
PRLD was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about PRLD.
In the previous month the buy percentage consensus was at a similar level.
PRLD was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.191.015.105.5110.50 - -15.13% 328.57% 362.86% 782.35%
Up and Down Grades
Date Firm Action Rating
2024-12-11 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-11-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-19 HC Wainwright & Co. Upgrade Neutral -> Buy
2024-09-16 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-09-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-09-10 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-15 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-03-13 JMP Securities Initiate Market Outperform
2024-02-20 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-12-19 Morgan Stanley Downgrade Equal-Weight -> Underweight
2023-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-19 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-04 Barclays Maintains Equal-Weight -> Equal-Weight
2023-08-04 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-03-17 HC Wainwright & Co. Maintains Buy
2022-11-21 B of A Securities Downgrade Neutral -> Underperform
2022-11-17 HC Wainwright & Co. Maintains Buy
2022-11-15 Morgan Stanley Maintains Equal-Weight
2022-09-09 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-07-29 Jefferies Initiate Buy
2022-05-12 HC Wainwright & Co. Maintains Buy
2022-02-28 Barclays Downgrade Overweight -> Equal-Weight
2021-11-17 Barclays Maintains Overweight
2021-10-11 Morgan Stanley Upgrade Equal-Weight -> Overweight
2021-10-08 Barclays Maintains Overweight
2021-07-27 B of A Securities Upgrade Neutral -> Buy
2021-04-26 HC Wainwright & Co. Initiate Buy
2021-03-17 Morgan Stanley Maintains Equal-Weight